Nodular Lymphocyte Predominant Hodgkin Lymphoma, Extranodal and Solid Organ Sites (C81.09)

Name of the Condition

• Common Name: Nodular Lymphocyte Predominant Hodgkin Lymphoma, Extranodal and Solid Organ Sites
• Medical Terms: NLP Hodgkin Lymphoma, Lymphocyte-Predominant Hodgkin Lymphoma

Summary

Nodular lymphocyte predominant Hodgkin lymphoma (NLP Hodgkin lymphoma) is a rare subtype of Hodgkin lymphoma that originates in the lymphatic system. It is characterized by the presence of large, abnormal cells known as lymphocyte-predominant (LP) cells, which are distinct from the Reed-Sternberg cells seen in other Hodgkin lymphoma subtypes. The disease typically involves lymph nodes and may spread to other lymphoid tissues or organs. NLP Hodgkin lymphoma tends to have a more indolent course compared to other subtypes, with a higher likelihood of late relapses.

Causes

The exact cause of NLP Hodgkin lymphoma is not fully understood, but it is thought to result from a combination of genetic mutations and environmental factors. Unlike other Hodgkin lymphoma subtypes, Epstein-Barr virus (EBV) is rarely associated with NLP Hodgkin lymphoma. Research suggests that alterations in the B-cell receptor signaling pathway and other genetic abnormalities may play a role in its development.

Risk Factors

• Age: Most commonly diagnosed in adults, with a peak incidence in the 30-50 age range.
• Gender: Slightly more prevalent in males.
• Family history: A small increased risk may be associated with a family history of lymphoma.
• Immune system disorders: Conditions that weaken the immune system may increase risk.

Symptoms

Symptoms may include painless swelling of lymph nodes, fever, night sweats, unexplained weight loss, and fatigue. When involving extranodal or solid organ sites, symptoms may relate to the affected area, such as abdominal pain or organ-specific dysfunction.

Diagnosis

Diagnosis involves a combination of physical examination, imaging studies (e.g., CT, PET scans), and biopsy of affected tissue. Histopathological analysis is required to identify LP cells and rule out other conditions. Immunohistochemistry and flow cytometry may be used to confirm the diagnosis.

Treatment Options

Treatment depends on the stage and location of the disease. Options may include radiation therapy, chemotherapy, immunotherapy, or a combination of these. Clinical trials may be available for eligible patients.

Prognosis and Follow-Up

NLP Hodgkin lymphoma generally has a favorable prognosis, especially when diagnosed early. However, late relapses can occur, necessitating long-term follow-up. Regular monitoring with physical exams and imaging is recommended.

Complications

Potential complications include disease recurrence, transformation to a more aggressive lymphoma, and treatment-related side effects such as infection risk or organ damage.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including a balanced diet and regular exercise, may support overall well-being. Avoiding known carcinogens and managing immune system health may help reduce risk, though specific prevention strategies are not established.

When to Seek Professional Help

Seek medical attention if you experience persistent lymph node swelling, unexplained weight loss, fever, or other concerning symptoms. Early evaluation is important for timely diagnosis and treatment.

Tips for Medical Coders

Code C81.09 is used for nodular lymphocyte predominant Hodgkin lymphoma involving extranodal and solid organ sites. Documentation should specify the affected site(s) to support accurate coding. Ensure the diagnosis aligns with histopathological confirmation of LP cells and exclusion of other Hodgkin lymphoma subtypes.